(Q38043420)

27 August 2017

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas (English)

1 reference

27 August 2017

1 reference

Eugene I Hwang

1

1 reference

27 August 2017

Regina I Jakacki

2

1 reference

27 August 2017

Michael J Fisher

3

1 reference

27 August 2017

Lindsay B Kilburn

4

1 reference

27 August 2017

Marianna Horn

5

1 reference

27 August 2017

Gilbert Vezina

6

1 reference

27 August 2017

Brian R Rood

7

1 reference

27 August 2017

Roger J Packer

8

1 reference

27 August 2017

13 September 2012

1 reference

27 August 2017

Pediatric Blood Cancer

1 reference

27 August 2017

60

1 reference

27 August 2017

5

1 reference

27 August 2017

776-782

1 reference

Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program

27 August 2017

1 reference

Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130).

21 January 2018

1 reference

Survival and functional outcome of children with hypothalamic/chiasmatic tumors.

21 January 2018

1 reference

Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update

21 January 2018

1 reference

Treatment results of juvenile pilocytic astrocytoma

21 January 2018

1 reference

Outcome analysis of childhood low-grade astrocytomas

21 January 2018

1 reference

Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits

21 January 2018

1 reference

Survival and long-term health and cognitive outcomes after low-grade glioma

21 January 2018

1 reference

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

21 January 2018

1 reference

Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial

21 January 2018

1 reference

A lower-dose, lower-toxicity cisplatin-etoposide regimen for childhood progressive low-grade glioma

21 January 2018

1 reference

Temozolomide in children with progressive low-grade glioma

21 January 2018

1 reference

Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

21 January 2018

1 reference

Pediatric low-grade gliomas and the need for new options for therapy: Why and how?

21 January 2018

1 reference

Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018.

21 January 2018

1 reference

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

21 January 2018

1 reference

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas

21 January 2018

1 reference

The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24297

1 reference

27 August 2017

1 reference